Table 3.
N | Number of death | % Death of study population | OR (95% CI) | P value | |
---|---|---|---|---|---|
Age |
|
|
|
|
|
<40 |
63 |
22 |
22.7 |
1 |
0.1 |
>40 |
34 |
7 |
7.2 |
0.5 (0.2 – 1.3) |
|
Sex |
|
|
|
|
|
Female |
51 |
11 |
11.8 |
1 |
0.06 |
Male |
46 |
18 |
18.6 |
2.3 (0.9 – 5.8) |
|
Altered sensorium |
|
|
|
|
|
No |
74 |
16 |
16.5 |
1 |
0.002 |
Yes |
23 |
13 |
13.4 |
4.7 (1.6 – 13.5) |
|
Focal signs |
|
|
|
|
|
No |
33 |
4 |
4.1 |
1 |
0.006 |
Yes |
64 |
25 |
25.8 |
4.6 (1.4 – 15.6) |
|
Seizures |
|
|
|
|
|
No |
41 |
7 |
7.2 |
1 |
0.02 |
Yes |
56 |
22 |
22.7 |
3.1 (1.1 – 8.6) |
|
Neck stiffness |
|
|
|
|
|
No |
82 |
21 |
21.6 |
1 |
0.03 |
Yes |
15 |
8 |
8.2 |
3.3 (1.1 – 10.2) |
|
CD4 cell count |
|
|
|
|
|
>100/mm3 |
26 |
3 |
3.1 |
1 |
0.001 |
<100/mm3 |
71 |
26 |
26.8 |
4.4 (1.5 – 16.9) |
|
Total | 97 | 29 | 29.9 | / | / |